ALS - Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), and Lou Gehrig's disease, is a disease which causes the death of neurons controlling voluntary muscles.

ALS is not included in the list of indications by the Israeli Ministry of Health. However, patients with the disease can receive a license to cannabis as a supportive treatment for pain, sleep disorders, appetite and mood improvement. Geriatric patients may apply for a doctor's recommendation without the need for a neurologist's approval.

We provide professional counseling for treatment and strains to our patients, in a set meeting with one of our registered nurses in our clinic.

► Medical Cannabis and ALS: 

Research

Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials
 
Carter GT, Abood ME, Aggarwal SK, Weiss MD
Muscular Dystrophy Association/Amyotrophic Lateral Sclerosis Center, University of Washington Medical Center, Seattle, WA, USA. gtcarter@uw.edu
 
http://www.ncbi.nlm.nih.gov/pubmed/20439484

Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival

Weydt P, Hong S, Witting A, Möller T, Stella N, Kliot M
Department of Neurology, University of Washington, Seattle, WA 98195, USA. weydt@u.washington.edu

http://www.ncbi.nlm.nih.gov/pubmed/16183560

Survey of cannabis use in patients with amyotrophic lateral sclerosis

Amtmann D Weydt P, Johnson KL, Jensen MP, Carter GT
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington, USA
 
http://www.ncbi.nlm.nih.gov/pubmed/15055508
 

Marijuana in the management of amyotrophic lateral sclerosis

Carter GT, Rosen BS
Muscular Dystrophy Association (MDA), Neuromuscular Disease Clinic, Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington, USA
 
http://www.ncbi.nlm.nih.gov/pubmed/11467101